1Complete Laboratory Conversion Nomogram
| Analyte | Conversion Factor | Normal (Conventional) | Normal (SI Units) | Clinical Notes |
|---|
2Why Laboratory Units Differ Globally
The United States, most of South Asia (including India), and parts of Latin America adhere to conventional mass-concentration units—primarily mg/dL (milligrams per decilitre) and g/dL. In contrast, the United Kingdom, Europe, Canada, Australia, and the World Health Organization mandate Système International (SI) molar units—principally mmol/L and µmol/L.
This divergence produces frequent clinical friction when clinicians interpret overseas clinical trials, international clinical guidelines, and imported diagnostic hardware. For instance, the diagnostic fasting plasma glucose cut-off for diabetes is 126 mg/dL in the USA and India, which is exactly equivalent to 7.0 mmol/L in UK NICE guidelines.
3Key Clinical Conversion Pairs to Memorise
- Glucose (Factor 18): Divide mg/dL by 18 to obtain mmol/L. Fasting normal: 70–100 mg/dL (3.9–5.6 mmol/L). Diabetes threshold: ≥126 mg/dL (≥7.0 mmol/L). Critical hypoglycemia: <70 mg/dL (<3.9 mmol/L).
- Creatinine (Factor 88.4): 1 mg/dL ≈ 88.4 µmol/L. Normal adult male: 0.7–1.2 mg/dL (62–106 µmol/L).
- Total Cholesterol (Factor 38.67): Divide mg/dL by 38.67 for mmol/L. Desirable: <200 mg/dL (<5.17 mmol/L). Target LDL in high ASCVD risk: ≤70 mg/dL (≤1.81 mmol/L).
- Triglycerides (Factor 88.57): Divide mg/dL by 88.57 for mmol/L. Hypertriglyceridemia: ≥150 mg/dL (≥1.70 mmol/L). Severe pancreatitis risk threshold: ≥500 mg/dL (≥5.65 mmol/L).
- Total Bilirubin (Factor 17.1): Multiply mg/dL by 17.1 for µmol/L. Clinical scleral icterus typically manifests when bilirubin exceeds 2.5–3.0 mg/dL (43–51 µmol/L).
- Uric Acid (Factor 59.48): Divide mg/dL by 59.48 for mmol/L (or multiply by 59.48 for µmol/L). Treat-to-target chronic gout threshold: <6.0 mg/dL (<357 µmol/L).